Back
53
20
Day Range
$28.18
$28.18
52-Week Range
$28.18
$28.18
Volume
300
50D / 200D Avg
$28.18
/
$28.18
Prev Close
$28.18
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.1 | 0.3 |
| P/B | 0.0 | 3.0 |
| ROE % | 11.8 | 3.7 |
| Net Margin % | 3.8 | 3.8 |
| Rev Growth 5Y % | 6.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.05
$1.98 – $2.19
|
1.01T | 1 |
| FY2029 |
$1.96
$1.89 – $2.10
|
965.67B | 1 |
| FY2028 |
$1.96
$1.89 – $2.09
|
951.91B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | $0.53 | $0.49 | -7.9% |
| 2025-08-14 | $0.48 | $0.47 | -1.4% |
| 2025-05-13 | $0.39 | $0.41 | +3.9% |
| 2025-02-12 | $0.49 | $0.52 | +5.5% |
| 2024-11-14 | $0.44 | $0.40 | -9.0% |
| 2024-08-14 | $0.38 | $0.39 | +2.9% |
| 2024-05-15 | $0.35 | $0.36 | +3.4% |
| 2024-02-14 | $0.53 | $0.53 | +0.6% |
Dividend History
Yield
0.03%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Jun 01, 2026 | $0.42 | 3.03% |
| Sep 30, 2025 | Dec 01, 2025 | $0.44 | 3.09% |
| Mar 31, 2025 | Jun 23, 2025 | $0.43 | 3.15% |
| Sep 30, 2024 | Dec 10, 2024 | $0.45 | 2.95% |
| Mar 28, 2024 | Jun 24, 2024 | $0.38 | 3.11% |
| Sep 28, 2023 | Dec 04, 2023 | $0.38 | 3.11% |
| Mar 30, 2023 | Jun 26, 2023 | $0.38 | 2.96% |
| Sep 29, 2022 | Dec 05, 2022 | $0.35 | 2.63% |
| Mar 30, 2022 | Jun 27, 2022 | $0.30 | 2.40% |
| Sep 29, 2021 | Dec 06, 2021 | $0.31 | 2.00% |
| Mar 30, 2021 | Jun 28, 2021 | $0.32 | 1.74% |
| Sep 29, 2020 | Dec 14, 2020 | $0.33 | 1.73% |
| Mar 30, 2020 | Jun 22, 2020 | $0.31 | 1.98% |
| Sep 27, 2019 | Dec 09, 2019 | $0.31 | 1.87% |
| Mar 27, 2019 | Jun 24, 2019 | $0.30 | 2.07% |
| Sep 26, 2018 | Dec 10, 2018 | $0.29 | 1.70% |
| Mar 28, 2018 | Jun 25, 2018 | $0.31 | 1.22% |
| Sep 27, 2017 | Dec 08, 2017 | $0.24 | 1.47% |
| Mar 29, 2017 | Jun 26, 2017 | $0.50 | 1.34% |
| Sep 28, 2016 | Dec 09, 2016 | $0.45 | 1.08% |
Key Takeaways
Revenue grew 6.03% annually over 5 years — modest growth
ROE of 11.76% — decent returns on equity
Debt/Equity of 0.14 — conservative balance sheet
Generating 6.90B in free cash flow
P/E of 0.11 — trading at a low valuation
Capital efficient — spends only 4.27% of revenue on capex
Growth
Revenue Growth (5Y)
6.03%
Revenue (1Y)6.66%
Earnings (1Y)5.58%
FCF Growth (3Y)801.88%
Quality
Return on Equity
11.76%
ROIC10.82%
Net Margin3.84%
Op. Margin5.55%
Safety
Debt / Equity
0.14
Current Ratio1.69
Interest Coverage271.32
Valuation
P/E Ratio
0.11
Forward P/EN/A
P/B Ratio0.01
EV/EBITDA-0.52
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.66% | Revenue Growth (3Y) | 7.76% |
| Earnings Growth (1Y) | 5.58% | Earnings Growth (3Y) | 9.38% |
| Revenue Growth (5Y) | 6.03% | Earnings Growth (5Y) | 4.97% |
| Profitability | |||
| Revenue (TTM) | 801.81B | Net Income (TTM) | 30.75B |
| ROE | 11.76% | ROA | 6.93% |
| Gross Margin | 25.45% | Operating Margin | 5.55% |
| Net Margin | 3.84% | Free Cash Flow (TTM) | 6.90B |
| ROIC | 10.82% | FCF Growth (3Y) | 801.88% |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 1.69 |
| Interest Coverage | 271.32 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.11 | Forward P/E | N/A |
| P/B Ratio | 0.01 | P/S Ratio | 0.00 |
| PEG Ratio | 2.89 | Forward PEG | N/A |
| EV/EBITDA | -0.52 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 209.25% | ||
| Market Cap | 3.30B | Enterprise Value | -22.99B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 801.81B | 751.78B | 690.46B | 648.73B | 634.31B |
| Net Income | 30.75B | 29.13B | 25.70B | 23.85B | 25.33B |
| EPS (Diluted) | 262.91 | 249.07 | 219.82 | 204.01 | 216.63 |
| Gross Profit | 204.09B | 189.32B | 1.29B | 1.29B | 1.43B |
| Operating Income | 44.50B | 41.00B | 37.45B | 34.05B | 37.35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 444.01B | 420.21B | 2.72B | 2.68B | 2.79B |
| Total Liabilities | 174.29B | 167.12B | 943.78M | 864.00M | 935.47M |
| Shareholders' Equity | 269.71B | 253.09B | 236.33B | 220.59B | 205.16B |
| Total Debt | 38.67B | 35.00B | 7.07M | 4.35M | 1.03M |
| Cash & Equivalents | 64.96B | 69.70B | 80.87B | 89.33B | 86.50B |
| Current Assets | 216.78B | 208.24B | 205.91B | 199.54B | 194.26B |
| Current Liabilities | 128.51B | 155.47B | 113.25B | 96.05B | 95.12B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#252 of 827
#464 of 709
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026